Company intelligence / Profile preview

Green Biologics

Abingdon, United Kingdom

Ownership: Private
Development stage: Other

Overview

Green Biologics is a revenue-generating and profitable industrial biotech company focused on advanced fermentation technologies. Its proprietary platform leverages thermophilic and anaerobic microorganisms (particularly Clostridia cultures) combined with metabolic pathway engineering to convert biomass into renewable chemicals and fuels, with a primary focus on butanol production from waste plant material for advanced biofuels and high-value chemicals. The company has demonstrated successful process development, completed intermediate-scale distillation separations, and validated process scalability, emphasizing the advantages of its heat-loving microorganisms.

Modalities: Fermentation-based bioproduction
Industry: Non-Drug Biotech

Partnerships

Catalysis and Chemicals Industry Association (CPI)

Beyond the preview

Go deeper on Green Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Green Biologics.

Explore the full profile